Biotech

All Articles

Novartis kindles new phase of Voyager treaty along with $15M capsid package

.Novartis levels a new outpost in its own collaboration along with Voyager Therapies, spending $15 m...

Lilly blog posts a lot more positive information on its own once a week insulin possibility

.On the heels of an FDA rejection for its own main rivalrous Novo Nordisk, Eli Lilly is actually pus...

IN 8bio halts phase 2 test, gives up one-half of staff

.Simply a few months after application the first person in a stage 2 test for freshly diagnosed glio...

Lilly, Haya ink $1B biobuck being overweight treaty to search darker genome

.Eli Lilly's search for weight problems aim ats has led it to the black genome. The Big Pharma has p...

ArsenalBio elevates $325M, rotates far from past lead property

.Collection Biosciences is proceeding up. The cell treatment firm has added $325 thousand in ammunit...

Lilly- backed fat loss biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' marijuana usage medicine flunks phase 2b, driving Indivior to rethink $100M choice

.Aelis Farma's chances of safeguarding a simple, good choice on a $100 thousand possibility payment ...

ProKidney standstills phase 3 test not needed to have for cell treatment approval

.ProKidney has actually stopped among a set of phase 3 tests for its own cell therapy for kidney ill...

Vaxcyte climbs on 'spectacular' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what analysts named "remarkable" period 1/2 information for its own 31-valent pneu...

Recursion's human brain health condition test reveals scant documentation of efficiency

.Recursion has discovered with an early examination of its tech-enabled technique to medication disc...